Neoadjuvant Talazoparib in Patients With Germline <i>BRCA1/2</i> Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study - Concepedia

Concepedia

Publication | Open Access

Neoadjuvant Talazoparib in Patients With Germline <i>BRCA1/2</i> Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study

DOI Full Paper Access

35

Citations

22

References

2023

Year

Jennifer K. Litton, J. Thaddeus Beck, Jason M. Jones, Jay Andersen, Joanne L. Blum, Lida A. Mina, Raymond Brig, Michael Danso, Yuan Yuan, Antonello Abbattista,

Abstract

NCT03499353.

References

	Year	Citations

Page 1